Silvercrest Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4M | Sell |
|
|||||
|
2025
Q1 | $23.7M | Buy |
|
|||||
|
2024
Q4 | $18.9M | Buy |
|
|||||
|
2024
Q3 | $15.6M | Buy |
|
|||||
|
2024
Q2 | $12.3M | Buy |
|
|||||
|
2024
Q1 | $2.7M | Buy |
|
|||||
|
2023
Q4 | $1.62M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.78M | Buy |
|
|||||
|
2022
Q3 | $2.87M | Sell |
|
|||||
|
2022
Q2 | $4.33M | Buy |
|
|||||
|
2022
Q1 | $4.34M | Buy |
|
|||||
|
2021
Q4 | $1.07M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $274K | Hold |
|
|||||
|
2014
Q3 | $278K | Hold |
|
|||||
|
2014
Q2 | $290K | Buy |
|
|||||
|
2014
Q1 | $241K | Hold |
|
|||||
|
2013
Q4 | $221K | Buy |
|